CVI Accepts, published online ahead of print on 25 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, Q. C.
Right arrow Articles by McDaniel, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, Q. C., III
Right arrow Articles by McDaniel, L. S.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00082-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae

Quincy C. Moore III, LaShundra Johnson, Michael Repka, and Larry S. McDaniel*

Departments of Microbiology, Surgery, and Medicine, University of Mississippi Medical Center, Jackson, MS 39216, and Department of Pharmaceutics, The University of Mississippi, University, MS 38677

* To whom correspondence should be addressed. Email: LmcDaniel{at}microbio.umsmed.edu.


arrow
Abstract

CBA/N mice were immunized with PspA in a poly(ethylene oxide) matrix to examine it's ability to deliver the antigen and modulate the immune response. All mice receiving PspA in the matrix survived a lethal pneumococcal challenge and had serum anti-PspA antibody levels statistically higher than mice receiving PspA alone (p<0.009).